ASND – ascendis pharma a/s - american depositary shares (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ASND

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/16

11:02 am

asnd

Rating for ASND

Low Report

Rating for ASND

Report

4/16

11:02 am

asnd

Rating for ASND

Low Report

Rating for ASND

Report

4/16

09:12 am

asnd

Ascendis Pharma A/S (NASDAQ: ASND) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $205.00 price target on the stock.

Medium Report

Ascendis Pharma A/S (NASDAQ: ASND) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $205.00 price target on the stock.

Report

4/16

09:12 am

asnd

Ascendis Pharma A/S (NASDAQ: ASND) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $205.00 price target on the stock.

Medium Report

Ascendis Pharma A/S (NASDAQ: ASND) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $205.00 price target on the stock.

Report

4/15

04:49 pm

asnd

Ascendis Pharma initiated with an Outperform at RBC Capital

Low Report

Ascendis Pharma initiated with an Outperform at RBC Capital

Report

4/15

04:49 pm

asnd

Ascendis Pharma initiated with an Outperform at RBC Capital

Low Report

Ascendis Pharma initiated with an Outperform at RBC Capital

Report

3/18

08:27 am

asnd

Rating for ASND

Medium Report

Rating for ASND

Report

2/25

09:15 am

asnd

Rating for ASND

Low Report

Rating for ASND

Report

2/18

10:27 am

asnd

Rating for ASND

Medium Report

Rating for ASND

Report

2/13

11:59 am

asnd

Rating for ASND

Low Report

Rating for ASND

Report

2/13

11:59 am

asnd

Rating for ASND

Low Report

Rating for ASND

Report

2/13

11:59 am

asnd

Rating for ASND

Low Report

Rating for ASND

Report

2/13

10:55 am

asnd

Rating for ASND

Low Report

Rating for ASND

Report

2/11

10:32 am

asnd

Ascendis Pharma A/S (NASDAQ: ASND) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $170.00 price target on the stock.

Low Report

Ascendis Pharma A/S (NASDAQ: ASND) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $170.00 price target on the stock.

Report

2/11

09:59 am

asnd

Rating for ASND

Low Report

Rating for ASND

Report

1/29

08:01 am

asnd

Rating for ASND

Low Report

Rating for ASND

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.